Fully compliant with Ministry of Health (MOH) Oman specifications, GCC DRAP standards, and European CE MDR regulatory frameworks.
Navigating Oman’s Ministry of Health Procurement Protocols, GCC Joint Tenders, and Specialized Surgical Demands.
The Ministry of Health (MOH) Oman and the Directorate General of Pharmaceutical Affairs and Drug Control (DGPAD) maintain stringent registration mandates. Our products are exported with full technical dossiers—including CE Certificates under EU MDR 2017/745, ISO 13485:2016 audit logs, Free Sale Certificates (FSC), and ISO 10993 Biocompatibility test reports—ensuring seamless approval for public hospital tenders in Muscat, Salalah, and Sohar.
Oman participates actively in the Gulf Cooperation Council (GCC) Joint Procurement System. Our medical wound-closure lines align precisely with GCC unified technical specifications, offering standard USP color-coding, robust primary aluminum foil barriers engineered for high-ambient Middle Eastern temperatures, and unified barcode labeling (GS1 / UDI standard) for hospital inventory management.
Operating in ambient Middle Eastern climates where summer warehouse temperatures exceed 40°C demands specialized primary packaging. Our medical-grade, double-envelope aluminum foil system prevents humidity ingress and thermal degradation, guaranteeing a stable 5-year shelf life for absorbable polymers such as PGA, PGLA 910, and Polydioxanone (PDO).
Synthesized for optimal knot security, minimal tissue drag, and predictable hydrolytic or enzymatic absorption profiles.
| Suture Material | Polymer Composition | Structure & Coating | Tensile Retention Profile | Mass Absorption Time | Clinical Applications in Oman |
|---|---|---|---|---|---|
| Netcryl (PGLA 910) | Poly(glycolide-co-L-lactide) 90/10 | Braided, Coated with Polycaprolactone & Calcium Stearate | 75% at 14 Days 50% at 21 Days |
56 – 70 Days | General Surgery, OB/GYN, Episiotomy, Gastrointestinal Closure. |
| Netsorb (PGA) | 100% Polyglycolic Acid | Braided, Low-drag Synthetic Coating | 65% at 14 Days 40% at 21 Days |
60 – 90 Days | Ophthalmic, Pediatric Surgery, Omani MOH Tender Specifications. |
| Netsynth (PDO / PDS) | Polydioxanone Monofilament | Monofilament, Uncoated Smooth Surface | 75% at 14 Days 50% at 28 Days |
180 – 210 Days | Abdominal Wall Fascia Closure, Pediatric Cardiac Surgery, Orthopedics. |
| Netcryl Mono (PCL) | Poliglecaprone-25 | Monofilament, High Flexibility | 60% at 7 Days 30% at 14 Days |
91 – 119 Days | Subcuticular Skin Closure, Plastic & Reconstructive Surgery. |
| Netlene (Polypropylene) | Isotactic Polypropylene | Monofilament Non-Absorbable | Indefinite (Permanent Support) | Non-Absorbable | Cardiovascular Anastomosis, Vascular Grafting, Hernia Mesh Fixation. |
| Netplast (Nylon) | Polyamide 6 / 6.6 | Monofilament Non-Absorbable | Loses ~15-20% per year via slow hydrolysis | Non-Absorbable | Ophthalmic (10-0/9-0), Cuticular Closure, Neurosurgery. |
| Netgut (Chromic Catgut) | Purified Bovine Intestinal Collagen | Twisted Monofilament, Chromic Salt Treated | Tensile retention 14 – 21 Days | 90 Days (Enzymatic) | Veterinary Surgery (Camels, Equine, Livestock), Ophthalmic/Mucosa. |
Suture performance is intrinsically linked to needle geometry and alloy composition. Our needles are crafted from premium 300-series (AISI 302/304/420) stainless steel, treated to achieve optimal yield strength and ductility. This prevents bending under dense anatomical resistance (such as sternum or tough scar tissue) while avoiding brittle fracture inside the surgical field.
Every swaged needle undergoes proprietary multi-stage siliconization. This ultra-thin silicone coating reduces initial tissue penetration force by up to 30%, minimizing trauma during repeated passes. For delicate procedures in plastic and cardiovascular surgery, our Tapercut and Micro-Point Reverse Cutting needles maintain edge sharpness through multiple passes without dulling.
Deploying specialized surgical threads across Sultanate medical centers, regional trauma hubs, and agricultural projects.
In tertiary institutions like the Royal Hospital Muscat, Khoula Hospital (National Trauma Center), and Sultan Qaboos University Hospital (SQUH), surgical demands require strict standardization. Our range of USP 10-0 micro-nylon to USP 2 high-tensile PGLA 910 supports high-volume operations spanning cardiothoracic, orthopedic joint replacement, and neurosurgical procedures.
Oman’s growing private healthcare infrastructure—including networks like Aster Al Raffah, NMC Healthcare Oman, and Badr Al Samaa Group—benefits from our low-reactivity Poliglecaprone-25 (Netcryl Mono) and Rapid PGLA sutures. These materials provide outstanding cosmetic subcuticular outcomes, reducing scar formation in cesarean sections, gynecological surgeries, and aesthetic plastic procedures.
Veterinary medicine in Oman spans high-value racing camels (Royal Camel Corps), equine clinics, and rural livestock across Dhofar (Salalah) and Al Batinah regions. Our high-tensile Heavy-Gauge PGA, Chromic Catgut, and Heavy Nylon sutures are optimized to withstand heavy physiological tension in large-animal laparotomy, tendon repair, and soft-tissue surgery.
Aligning surgical supply chains with national healthcare expansion, digitalization, and infection control mandates.
Under Oman Vision 2040, the Ministry of Health encourages private sector participation to decentralize specialized care away from Muscat. This shift increases the demand for reliable, direct-from-manufacturer surgical consumables that offer European CE standards at competitive price points, reducing operational expenditure for growing medical groups.
Surgical Site Infections (SSIs) impose significant economic burdens on health systems. Omani hospital procurement committees are actively adopting Triclosan-Coated Polyglactin 910 and PGA sutures. Our antibacterial lines create a zone of inhibition against pathogens such as Staphylococcus aureus and Staphylococcus epidermidis, meeting stringent hospital infection control guidelines.
Laparoscopic and robotic procedures across Oman’s modern surgical theaters are shifting towards knotless barbed sutures (PDO/PGLA). Barbed sutures eliminate manual knot tying, distribute tension evenly across incisions, and reduce operative time by up to 25% in complex pelvic, urological, and bariatric operations.
Addressing technical, regulatory, shipping, and tender compliance queries for surgical supplies in Oman.
We provide complete regulatory dossiers required by the Directorate General of Pharmaceutical Affairs and Drug Control (DGPAD) Oman. This includes ISO 13485:2016 Certification, CE Certificate under EU MDR 2017/745, Certificate of Free Sale (FSC), WHO-GMP, Certificate of Analysis (CoA) per lot, and ISO 10993 Biocompatibility testing validation.
We support both Sea Freight via Sohar Port and Sultan Qaboos Port, as well as Air Freight via Muscat International Airport (MCT). Orders are dispatched in temperature-controlled shipping containers with moisture-resistant outer master cartons to prevent ambient heat damage during transit.
Yes. We offer turnkey OEM and private-label manufacturing. We can customize the primary foil packaging, inner foil prints, outer shelf boxes, GS1/UDI barcodes, and multi-lingual Instructions for Use (IFU)—including dual Arabic/English labeling to comply with Omani market standards.
Our absorbable sutures are packed in hermetically sealed air-tight aluminum foil packets inside Cleanroom Class 100,000 (ISO Class 8) environments. Real-time and accelerated stability testing confirm product integrity and sterile barrier preservation when stored below 25°C, even after international transport.
Standard catalog product lines dispatch within 2 to 4 weeks. Custom OEM and private-label orders, requiring specialized brand artwork approval and custom needle-thread configurations, typically ship in 5 to 7 weeks for initial batches, with expedited timelines for repeat container orders.
Yes, we provide sample boxes to verified medical device importers, hospital procurement officers, and ministry tender agents across Oman for surgeon evaluation, needle attachment pull-testing, and knot security trials.
Eliminating supply chain fragmentation from raw polymer synthesis to final sterile foil packaging.
All production processes—including polymer extrusion, precision braiding, silicone micro-coating, automated needle attachment (swaging), EO gas sterilization, and secondary packaging—take place in our single integrated facility in Bengaluru. This single-site approach guarantees strict quality control without third-party outsourcing.
Every single box of sutures exported to Oman contains a unique lot tracking code. This lot links directly back to the raw material polymer batch certificate, the needle steel heat number, the specific swaging machine calibration log, and the Ethylene Oxide sterilization chamber chart, retrievable for 11 years for post-market surveillance.
Our quality assurance testing lab verifies 100% of production lots against United States Pharmacopeia (USP) and European Pharmacopoeia (EP) monographs. Tests include needle attachment pull-out strength, thread diameter consistency, tensile strength retention, knot pull resistance, and sterility assurance verification (SAL 10⁻⁶).
Request technical dossiers, pricing quotes, or sample evaluation kits for your hospital network or distribution enterprise in Oman.
